JAMA Network Home
Sign In
Research Letter

Buprenorphine Treatment for Opioid Use Disorder in Non–Addiction Specialty Settings

JAMA Network Open 10.1001/jamanetworkopen.2025.43543

November 13, 2025 at 11:00 AM EST

Read the full article

This cohort study evaluates changes in prescribing of buprenorphine treatment for opioid use disorder at primary care, mental health, and pain clinics and substance use disorder clinics in Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) and non-SCOUTT facilities.

Corresponding Author: Adam J. Gordon, MD, MPH, Department of Internal Medicine, University of Utah Health, 295 Chipeta Way, Salt Lake City, UT 84108 (adam.gordon@hsc.utah.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.43543?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111325

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks